Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SOFOSBUVIR, with a corresponding US DMF Number 31272.
Remarkably, this DMF maintains an Active status since its submission on September 01, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 27, 2017, and payment made on August 23, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II